2007-06-22T11:31:38
The Medicines and Healthcare products Regulatory Agency is writing to HIV specialists and patient organisations setting out an action plan following the recall of HIV/AIDS drug Viracept (nelfinavir) due to contamination.
With a HSJ subscription you’ll unlock:
Part of HSJ Information Ltd. 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud